Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory J Brunn

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
International Journal of Pharmaceutical Compounding|May 23, 2013
Nifedipine in compounded oral and topical preparationsSusan V McCluskey, Gregory J Brunn
Trends in Molecular Medicine|November 22, 2005
The etiology of sepsis: turned inside outGregory J Brunn, Jeffrey L Platt
Circulation Research|March 4, 2006
Differential regulation of endothelial cell activation by complement and interleukin 1alphaGregory J Brunn, Soheyla Saadi, Jeffrey L Platt
Circulation Research|February 23, 2008
Constitutive repression of interleukin-1alpha in endothelial cellsGregory J Brunn, Soheyla Saadi, Jeffrey L Platt
Discovery Medicine|January 20, 2007
Toward a modern concept of sepsis: new answers to ancient questionsGregory J Brunn, Marilou F Wijdicks, Jeffrey L Platt
Critical Reviews in Immunology|August 9, 2003
Activation of mammalian Toll-like receptors by endogenous agonistsGeoffrey B Johnson, Gregory J Brunn, Jeffrey L Platt
Journal of Immunology (Baltimore, Md. : 1950)|December 23, 2003
Cutting edge: an endogenous pathway to systemic inflammatory response syndrome (SIRS)-like reactions through Toll-like receptor 4Geoffrey B Johnson, Gregory J Brunn, Jeffrey L Platt
Journal of Leukocyte Biology|May 15, 2007
Pivotal advance: endogenous pathway to SIRS, sepsis, and related conditionsAmy H Tang, Gregory J Brunn, Marilia Cascalho, et al.
Thrombosis Research|June 2, 2009
Platelet response as a sentinel marker of toll-like receptor 4 activation in miceMuthuvel Jayachandran, Virginia M Miller, Gregory J Brunn, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2002
Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4Geoffrey B Johnson, Gregory J Brunn, Yuzo Kodaira, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
International Journal of Pharmaceutical Compounding|May 23, 2013
Nifedipine in compounded oral and topical preparationsSusan V McCluskey, Gregory J Brunn
Trends in Molecular Medicine|November 22, 2005
The etiology of sepsis: turned inside outGregory J Brunn, Jeffrey L Platt
Circulation Research|March 4, 2006
Differential regulation of endothelial cell activation by complement and interleukin 1alphaGregory J Brunn, Soheyla Saadi, Jeffrey L Platt
Circulation Research|February 23, 2008
Constitutive repression of interleukin-1alpha in endothelial cellsGregory J Brunn, Soheyla Saadi, Jeffrey L Platt
Discovery Medicine|January 20, 2007
Toward a modern concept of sepsis: new answers to ancient questionsGregory J Brunn, Marilou F Wijdicks, Jeffrey L Platt
Critical Reviews in Immunology|August 9, 2003
Activation of mammalian Toll-like receptors by endogenous agonistsGeoffrey B Johnson, Gregory J Brunn, Jeffrey L Platt
Journal of Immunology (Baltimore, Md. : 1950)|December 23, 2003
Cutting edge: an endogenous pathway to systemic inflammatory response syndrome (SIRS)-like reactions through Toll-like receptor 4Geoffrey B Johnson, Gregory J Brunn, Jeffrey L Platt
Journal of Leukocyte Biology|May 15, 2007
Pivotal advance: endogenous pathway to SIRS, sepsis, and related conditionsAmy H Tang, Gregory J Brunn, Marilia Cascalho, et al.
Thrombosis Research|June 2, 2009
Platelet response as a sentinel marker of toll-like receptor 4 activation in miceMuthuvel Jayachandran, Virginia M Miller, Gregory J Brunn, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2002
Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4Geoffrey B Johnson, Gregory J Brunn, Yuzo Kodaira, et al.
Pageof 3